Precursors to melanoma and their mimics: Nevi of special sites

Modern Pathology

Volumn 19, Issue , 2006, Pages 4-20

  Elder, David E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Acral nevi; Dysplastic nevi; Genital nevi; Malignant melanoma; Melanocytic nevi; Nevi of special sites

Indexed keywords

CANCER RISK; CANCER SURGERY; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; MELANOCYTE; MELANOMA; NEVUS; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR GROWTH;

DIAGNOSIS, DIFFERENTIAL; DYSPLASTIC NEVUS SYNDROME; HUMANS; MELANOCYTES; MELANOMA; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 31644448494     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800515     Document Type: Article

References (68)

1. Clark Jr WH, Reimer RR, Greene MH, et al. Origin of familial melanomas from heritable melanocytic lesions. ‘The B-K mole syndrome’. Arch Dermatol 1978;114:732-738.
2. Elder DE, Greene MH, Bondi EE, et al. Acquired melanocytic nevi and melanoma: the dysplastic nevus syndrome. In: Ackerman AB (ed). Pathology of Malignant Melanoma. Masson: New York, 1981, pp 185-216.
3. Elder DE, Green MH, Guerry DIV, et al. The dysplastic nevus syndrome: our definition. Am J Dermatopathol 1982;4:455-460.
4. Sagebiel RW, Banda PW, Schneider JS, et al. Age distribution and histologic patterns of dysplastic nevi. J Am Acad Dermatol 1985;13:975-982.
5. Clemente C, Cochran A, Elder DE, et al. Histopathologic diagnosis of dysplastic nevi. Concordance among pathologists convened by the WHO melanoma programme. Hum Pathol 1991;22:313-319.
6. De Wit PEJ, Vanr’t Hof-Grootenboer B, Ruiter DJ, et al. Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer [A] 1993;29A:831-839.
7. Arumi-Uria M, McNutt NS, Finnerty B. Grading of atypia in nevi: correlation with melanoma risk. Mod Pathol 2003;16:764-771.
8. Tucker MA, Fraser MC, Goldstein AM, et al. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 2002;94: 3192-3209.
9. Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin 1985;35:130-151.
10. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 2004;292:2771-2776.
11. Gachon J, Beaulieu P, Sei JF, et al. First prospective study of the recognition process of melanoma in dermatological practice. Arch Dermatol 2005;141: 434-438.
12. Rhodes AR, Harrist TJ, Day CL, et al. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 1983;9:563-574.
13. Duray PH, Ernstoff MS. Dysplastic nevus in histologic contiguity with acquired nonfamilial melanoma. Clinicopathologic experience in a 100-bed hospital. Arch Dermatol 1987;123:80-84.
14. Gruber SB, Barnhill RL, Stenn KS, et al. Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol 1989;21:773-780.
15. Marks R, Dorevitch AP, Mason G. Do all melanomas come from ‘moles’? A study of the histological association between melanocytic naevi and melanoma. Australas J Dermatol 1990;31:77-80.
16. Sagebiel RW. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness. J Invest Dermatol 1993;100:322S-325S.
17. Bevona C, Goggins W, Quinn T, et al. Cutaneous melanomas associated with nevi. Arch Dermatol 2003; 139:1620-1624.
18. Halpern AC, Guerry D, Elder DE, et al. Natural history of dysplastic nevi. J Am Acad Dermatol 1993;29:51-57.
19. Halpern AC, Guerry D, Elder DE, et al. A cohort study of melanoma in patients with dysplastic nevi. J Invest Dermatol 1993;100:346S-349S.
20. Kelly JW, Yeatman JM, Regalia G, et al. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance. Med J Aust 1997;167:191-194.
21. Wang SQ, Kopf AW, Koenig K, et al. Detection of melanomas in patients followed up with total cutaneous examinations, total cutaneous photography, and dermoscopy. J Am Acad Dermatol 2004;50:15-20.
22. Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985;45:1855-1861.
23. Swerdlow AJ, English J, MacKie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986;292:1555-1559.
24. Holly EA, Kelly JW, Shpall SN, et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987;17:459-468.
25. Evans RD, Kopf AW, Lew RA, et al. Risk factors for the development of malignant melanoma—I: Review of case-control studies. J Dermatol Surg Oncol 1988;14:393-408.
26. Augustsson A, Stierner U, Rosdahl I, et al. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereol (Stockh) 1991;71:518-524.
27. Halpern AC, Guerry DIV, Elder DE, et al. Dysplastic nevi as risk markers of sporadic (non-familial) melanoma: a case-control study. Arch Dermatol 1991;127:995-999.
28. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997;277:1439-1444.
29. Landi MT, Baccarelli A, Tarone RE, et al. DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst 2002;94:94-101.
30. Bliss JM, Ford D, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int J Cancer 1995;62: 367-376.
31. Ford D, Bliss JM, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995;62:377-381.
32. MacKie RM, Freudenberger T, Aitchison TC. Personal risk-factor chart for cutaneous melanoma. Lancet 1989;2:487-490.
33. Rhodes AR, Melski JW, Sober AJ, et al. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines. J Invest Dermatol 1983;80:452-459.
34. Ackerman AB, Briggs PL, Bravo F. Dysplastic nevus, compound type vs. Clark’s nevus, compound type. Differential diagnosis in dermatopathology III. In: Ackerman AB, Briggs PL, Bravo F (eds). Lea & Febiger: Philadelphia, 1993, pp 158-161.
35. Nollet DJ. ‘Clark’s nevus syndrome’ [letter]. Am J Dermatopathol 1986;8:367.
36. Steijlen PM, Bergman W, Hermans J, et al. The efficacy of histopathological criteria required for diagnosing dysplastic naevi. Histopathology 1988;12: 289-300.
37. Rhodes AR, Mihm Jr MC, Weinstock MA. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology. Modern Pathol 1989;2:306-319.
38. Duray PH, DerSimonian R, Barnhill R, et al. An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J Am Acad Dermatol 1992; 27:741-749.
39. Smoller BR, Egbert BM. Dysplastic nevi can be diagnosed and graded reproducibly: a longitudinal study. J Am Acad Dermatol 1992;27:399-402.
40. Duncan LM, Berwick M, Bruijn JA, et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol 1993;100:318S-321S.
41. Hartge P, Holly EA, Halpern AC, et al. Recognition and classification of clinically dysplastic nevi from photographs: a study of interobserver variation. Cancer Epidemiol, Biomarkers Prev 1995;4:37-40.
42. Meyer LJ, Piepkorn M, Goldgar DE, et al. Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia. J Am Acad Dermatol 1996;34:618-625.
43. Weinstock MA, Barnhill RL, Rhodes AR, et al. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel. Arch Dermatol 1997;133:953-958.
44. Brochez L, Verhaeghe E, Grosshans E, et al. Interobserver variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 2002;196:459-466.
45. Hastrup N, Clemmensen OJ, Spaun E, et al. Dysplastic naevus: histological criteria and their inter-observer reproducibility. Histopathology 1994;24:503-509.
46. Piepkorn MW, Barnhill RL, Cannon-Albright LA, et al. A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol 1994;30:707-714.
47. Piepkorn M, Meyer LJ, Goldgar D, et al. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989;20:407-415.
48. Klein LJ, Barr RJ. Histologic atypia in clinically benign nevi. A prospective study. J Am Acad Dermatol 1990; 22:275-282.
49. Hastrup N, Hou-Jensen K. Melanocytic lesions in a private pathology practice. Comparison of histologic features in different tumor types with particular reference to dysplastic nevi. APMIS 1993;101:845-850.
50. Elder DE, Xu X. The approach to the patient with a difficult melanocytic lesion. Pathology 2004;36: 428-434.
51. Elder DE, Guerry D, Epstein MN, et al. Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol 1984;6(Suppl):55-61.
52. Christensen WN, Friedman KF, Woodruff JD, et al. Histologic characteristics of vulval nevocellular nevi. J Cutan Pathol 1987;14:87-91.
53. Rock B. Pigmented lesions of the vulva. Dermatol Clin 1992;10:361-370.
54. Maize JC, Ackerman AB. Pigmented Lesions of the Skin. Clinicopathologic Correlations. Lea & Febiger: Philadelphia, 1987.
55. Rock B, Hood AF, Rock JA. Prospective study of vulvar nevi. J Am Acad Dermatol 1990;22:104-106.
56. Friedman RJ, Ackerman AB. Difficulties in the histologic diagnosis of melanocytic nevi on the vulvae of premenopausal women. In: Ackerman AB (ed). Pathology of Malignant Melanoma. Masson: New York, 1981, pp 119-127.
57. Shabrawi-Caelen L, Soyer HP, Schaeppi H, et al. Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge. J Am Acad Dermatol 2004;50:690-694.
58. Carlson JA, Mu XC, Slominski A, et al. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol 2002;138:77-87.
59. Rongioletti F, Urso C, Batolo D, et al. Melanocytic nevi of the breast: a histologic case-control study. J Cutan Pathol 2004;31:137-140.
60. MacKie RM, English J, Aitchison TC, et al. The number and distribution of benign pigmented moles (melanocytic nevi) in a healthy British population. Br J Dermatol 1985;113:167-174.
61. Rongioletti F, Ball RA, Marcus R, et al. Histopathological features of flexural melanocytic nevi: a study of 40 cases. J Cutan Pathol 2000;27:215-217.
62. Rhodes AR. Congenital nevomelanocytic nevi. Histologic patterns in the first year of life and evolution during childhood. Arch Dermatol 1986;122:1257-1262.
63. Betti R, Inselvini E, Vergani R, et al. Small congenital nevi associated with melanoma: case reports and considerations. J Dermatol 2000;27: 583-590.
64. Pulitzer DR, Martin PC, Cohen AP, et al. Histologic classification of the combined nevus: analysis of the variable expression of melanocytic nevi. Am J Surg Pathol 1991;15:1111-1122.
65. McCarthy SW, Scolyer RA. Melanocytic lesions of the face: diagnostic pitfalls. Ann Acad Med Singapore 2004;33:3-14.
66. Lazova R, Lester B, Glusac EJ, et al. The characteristic histopathologic features of nevi on and around the ear. J Cutan Pathol 2005;32:40-44.
67. Saad AG, Patel S, Mutasim DF. Melanocytic nevi of the auricular region: histologic characteristics and diagnostic difficulties. Am J Dermatopathol 2005;27: 111-115.
68. Elder DE. Skin cancer: melanoma and other specific nonmelanoma skin cancers. Cancer 1995;75(Suppl): 245-256.